ProfileGDS4284 / 214247_s_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 34% 37% 26% 31% 9% 17% 32% 32% 35% 25% 32% 37% 38% 24% 36% 42% 26% 18% 23% 22% 19% 17% 28% 26% 29% 21% 25% 30% 8% 25% 6% 24% 21% 32% 27% 9% 26% 25% 12% 30% 33% 29% 28% 11% 9% 34% 24% 28% 60% 23% 35% 29% 5% 10% 34% 26% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control87.231234
GSM687648Patient 402 control106.09737
GSM687653Patient 403 control60.246526
GSM687658Patient 404 control84.855931
GSM687663Patient 411 control17.63839
GSM687668Patient 422 control29.9617
GSM687673Patient 424 control96.607932
GSM687678Patient 425 control96.893432
GSM687683Patient 427 control113.65735
GSM687688Patient 428 control57.818125
GSM687695Patient 441 control147.1732
GSM687699Patient 443 control139.21237
GSM687704Patient 444 control117.8938
GSM687707Patient 448 control65.779424
GSM687712Patient 449 control110.136
GSM687719Patient 450 control175.86742
GSM687724Patient 451 control70.902826
GSM687728Patient 452 control36.550118
GSM687646Patient 401 treated 24h49.737923
GSM687649Patient 402 treated 24h42.78622
GSM687665Patient 411 treated 24h40.732819
GSM687651Patient 402 treated 4 weeks32.053817
GSM687667Patient 411 treated 4 weeks73.89928
GSM687670Patient 422 treated 24h64.791926
GSM687671Patient 422 treated 4 weeks71.551229
GSM687654Patient 403 treated 24h37.99821
GSM687675Patient 424 treated 24h65.347625
GSM687685Patient 427 treated 24h77.712930
GSM687656Patient 403 treated 4 weeks11.97418
GSM687677Patient 424 treated 4 weeks58.502725
GSM687687Patient 427 treated 4 weeks9.624596
GSM687692Patient 428 treated 4h54.118124
GSM687716Patient 449 treated 4h45.934521
GSM687722Patient 450 treated 4h103.29932
GSM687680Patient 425 treated 24h66.145527
GSM687690Patient 428 treated 24h14.26249
GSM687700Patient 443 treated 24h94.705626
GSM687705Patient 444 treated 24h55.178825
GSM687714Patient 449 treated 24h18.206812
GSM687721Patient 450 treated 24h98.544230
GSM687682Patient 425 treated 4 weeks92.925233
GSM687694Patient 428 treated 4 weeks66.144629
GSM687702Patient 443 treated 4 weeks74.803828
GSM687718Patient 449 treated 4 weeks19.663111
GSM687723Patient 450 treated 4 weeks16.93399
GSM687661Patient 404 treated 4h105.95434
GSM687710Patient 448 treated 4h52.053624
GSM687726Patient 451 treated 4h80.173928
GSM687730Patient 452 treated 4h586.01460
GSM687660Patient 404 treated 24h66.216223
GSM687697Patient 441 treated 24h145.20535
GSM687709Patient 448 treated 24h85.185929
GSM687725Patient 451 treated 24h13.33675
GSM687729Patient 452 treated 24h26.70310
GSM687727Patient 451 treated 4 weeks119.59834
GSM687731Patient 452 treated 4 weeks74.736826